Ashwagandha leads the ingredient category with 43.8% share, and stress represents 37.5% of application demand in 2026. Powder captures 46.2% by form through efficient handling across capsules and tablets used by contract manufacturers. Commercial expansion depends on authenticated plant material and repeatable marker profiles supported by finished-product testing and country-specific claim controls.